Development of a High-Performing Congenital Heart Program in Vietnam

Chau P Nguyen1, Huu Nhat Nguyen2, Sarah Tabbutt3

  • 1Division of Cardiology, Department of Pediatrics, Emory University/Children's Healthcare of Atlanta, Atlanta, GA, USA.

Insights

A partnership enhanced congenital heart surgery outcomes at Vietnam National Children's Hospital (VNCH), a high-volume center. VNCH showed comparable results to North American centers, with areas for future improvement in complex cases.

Area of Science:

  • Pediatric Cardiac Surgery
  • Global Health Equity
  • Quality Improvement in Healthcare

Background:

  • Children's HeartLink and UCSF partnered with Vietnam National Children's Hospital (VNCH) in 2017.
  • VNCH is a high-performing center among low- and middle-income countries (LMICs) in congenital heart disease care.
  • This study compares VNCH outcomes to North American centers using Pediatric Cardiac Critical Care Consortium (PC4) data.

Purpose of the Study:

  • To compare the surgical outcomes of VNCH with North American centers in 2023.
  • To evaluate the impact of a long-term partnership on congenital heart surgery outcomes in an LMIC setting.
  • To identify specific areas for continued improvement at VNCH.

Main Methods:

  • Leveraged data from the Pediatric Cardiac Critical Care Consortium (PC4) for North American centers and VNCH data for 2023.
  • Utilized a partnership model involving semiannual training visits and weekly case conferences from UCSF volunteers.
  • Converted Risk Adjustment for Congenital Heart Surgery (RACHS-1) scores to STAT scores for outcome comparison.

Main Results:

  • VNCH performed 1,056 operations, compared to 14,506 in PC4 centers.
  • VNCH demonstrated comparable overall outcomes but had higher surgical mortality for infants with prematurity and noncardiac abnormalities, and a higher rate of surgical site infections.
  • VNCH performed fewer operations on patients with noncardiac abnormalities and higher STAT scores.

Conclusions:

  • Partnerships between well-resourced and under-resourced centers can significantly improve congenital heart surgery outcomes.
  • VNCH is a high-volume center with respectable outcomes, demonstrating the success of the collaborative model.
  • Future efforts should focus on increasing STAT level and neonatal surgeries at VNCH.

Related Concept Videos

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
2.0K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
323
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
451
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
207
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
671
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
10.8K